|Articles|March 1, 2018
- Pharmaceutical Executive-03-01-2018
- Volume 38
- Issue 3
Pharmaceutical Executive, March 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Pharma: Meet Your New Neighborsabout 8 years ago
Risk Sharing, Italian Styleabout 8 years ago
The Quest to Measure Upabout 8 years ago
Full Disclosure Demanded for Pharma Industryabout 8 years ago
Setting the Standard: William Soliman, ACMAabout 8 years ago
The Law of Unintended Consequencesabout 8 years ago
Pricing Turning Point: The Case for Innovating Pharma’s Modelabout 8 years ago
Showdown Nears on Europe Research Incentivesabout 8 years ago
The Personalized Genetic Profile: It’s Time to Alignabout 8 years ago
Country Report: IndiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Impact Could Recent US Regulatory Actions Have on Global Pricing and Launches?
2
Why Ireland Has Become a Strategic Hub for the Global Pharmaceutical Industry
3
Pharma M&A Roundup: IMG Pharma Acquires Matsumoto Pharmaceutical, Sun Pharma Acquires Organon
4
FDA Approves Breztri for Patients 12 Years and Older with Asthma
5